Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND):

Allows users to copy and distribute the Article, provided this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way, and provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, and that the licensor is not represented as endorsing the use made of the work. The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.

Copyediting and Proofs

Manuscripts must be written either in good American or British English, in a clear language, correct punctuations, and consistent style throughout the manuscript. Authors are advised to send for professional English language editing service before submission. (Viser Manuscript Submission Template)

Editorial Policies

Peer Review

Viser Technology Pte. Ltd. follows a double-blind peer-review procedure for submissions of all manuscripts to its journals.

All submitted manuscripts are subjected to a fair, unbiased, and extensive peer review in consultation with the assigned journal's Editorial Board Member and independent internal or external referees (usually two reviewers), which have expertise in the field of the submitted manuscripts. The peer-review applies a short and rapid, but fair and professional assessment on all submitted manuscripts. The journal's Editor-in-Chief is then decided on the submitted manuscripts based on all the peer reviewers' comments before conveying to the author(s).

All submissions from the Editor-in-Chief will undergo independent peer-review and assess by the journal's Editorial Board Member or in-house Editor for the decision on acceptance.

Ethical Approval of Studies and Informed Consent

For human or animal experimental investigations, it is a prerequisite to provide a formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee, which should be documented in the paper. For investigations undertaken on human subjects, the manner in which the informed consent was obtained from the study participants (i.e., oral or written) should be stated clearly in the Materials and Methods section.

The authors must obtain patient consent either orally or written when they use confidential case material. However, patient consent is not required for very brief case vignettes that do not contain identifying information or if the case material is masked sufficiently to prevent the identification of the patient.

The authors should inform and discuss with the recruiting patients on the purpose(s) of publication, the possible risks and benefits to obtain, and the patient's right to withhold or withdraw consent. In the case of a minor patient, consent should be obtained from the parent(s) or guardian(s). The authors should not perform any misconduct or deceive the recruiting patients in obtaining their consent.

Standard Protocol on Approvals, Registrations, Patients Consents & Animal Protection

Human: All clinical investigations must be conducted according to the Declaration of Helsinki principles, as revised in 2000 and 2008. Authors must comply with the guidelines of the International Committee of Medical Journal Editors (www.icmje.org) in conjunction with the patient's consent for research or participation in a study. Patients' names, initials, or hospital numbers must not be mentioned anywhere in the manuscript (including figures). Editors may request the authors to provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study if necessary.

Animals: All original research manuscripts involving the use of animals, the authors should indicate whether relevant international, national, and/or institutional guidelines for the care and use of laboratory animals were conducted accordingly. The authors must include details of animal welfare (such as species, number, gender, age, weight, housing conditions, welfare, training and the fate of the animals at the end of the experiment) and relevant details of steps taken to ameliorate suffering in all works in the Materials and Method section of a manuscript. Similarly, any experiments involving animals from clients or private institutions, the authors are required to get informed client consent and adhere to a high standard (best practice) of veterinary care. These details should be included in the Materials and Methods section of the manuscript.

Publishing Ethics

Publishing Policies

Viser Technology Pte. Ltd. requests all members involved in the journal publishing process to adhere to the "Code of Conduct for Journal Editors" and "Code of Conduct for Journal Publishers" as stipulated by COPE (Committee on Publication Ethics).

The publisher strictly adheres to the guidelines and best practices, which include Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical JournalsEditors (ICMJE) and the Principles of Transparency and Best Practice in Scholarly Publishing developed by Committee on Publication Ethics (COPE), Directory of Open Access Journals (DOAJ), Open Access Scholarly Publishers Association (OASPA) and World Association of Medical Editors (WAME).

期刊以“平面媒体+网络传播”方式互动，内容聚焦智能城市建设，解读行业政策，传播行业技术标准；组建权威的业内专家团队，为期刊提供精粹的观点、尖端技术解读；以科技成果传播为核心，关注自主创新，宣传展示各地智能城市建设成就；剖析各领域典型应用案例，分享最新技术理论与产品，全方位深度覆盖诸多物联网与智能城市应用领域，为相关信息化管理部门及广大设计院、系统集成商、建筑工程公司、房地产开发商、物业管理公司、产品生产厂商等相关单位提供各类参考资料。

鼓励智能城市建设领域的专业技术人员和管理干部以及大专院校相关专业的师生和科研人员来稿，有关国家科技计划、自然科学基金和各种部门、地方、院所科技基金资助项目的文章优先发布。

ISSN: 2630-5305 (online)

ISSN: 2717-5391 (print)

The publication frequency of this journal is Monthly

• CrossRef
• CNKI

• China Science and Technology Journal Database

Email: smart_city_appl@outlook.com

This journal charges an article processing charge of S$ 300.00 (Singapore Dollars)

Viser Technology provides the following payment channels. Upon reception of the invoice from Viser, you may choose one of the following payment methods that suit you the most.

Bank Transfer / Wire Transfer

• Bank: DBS Bank Ltd
• Account Name: Viser Technology Pte Ltd
• Account No.: 023-906417-5
• Swift Code: DBSSSGSG

Alipay / Wechat Pay

Scan the following QR code for payment

UnionPay

Viser supports payments via UnionPay. If you wish to make the payment using a UnionPay enabled credit/debit card, please contact us at viser-tech@outlook.com to request for the payment link to be sent to your email address. Once you have received the payment request email, click on the link to go to the secure UnionPay payment page to complete the payment.

In your payment request email, please indicate the following information:

• Author Name(s)
• Article Number
• Article Title
• Journal Title

Should you encounter any problem related to payment, please contact viser-tech@outlook.com for assistance.

经国务院批准，由中国科学技术协会、交通运输部、中国工程院共同主办，中国公路学会承办，国内外交通运输科研机构、院校、企事业单位和社会组织的共同支持的2019世界交通运输大会，定于2019年6月13日至16日在北京国家会议中心举行。6月13日报到，6月14日-16日开会。大会以“智能绿色引领未来交通”为主题，内容涵盖学术交流、成果推广、产品展示、国际合作、科技竞赛、学科报告与标准发布等内容，旨在为世界交通运输行业提供酝酿创新、主导创新、展示创新和实施创新的国际化交流平台。

会议时间：
2019年6月13日至16日
6月13日：代表报到及闭门会议；
6月14日至16日：大会开幕…